FCH
GMAB icon

Freestone Capital Holdings’s Genmab GMAB Stock Holding History

Freestone Capital Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-146
Closed -$5.94K – 668
2020
Q4 		$5.94K Sell
146
-125
-46% -$4.67K ﹤0.01% 963
2020
Q3 		$9.92K Sell
271
-6,411
-96% -$232K ﹤0.01% 746
2020
Q2 		$226 Sell
6,682
-15,433
-70% -$421K ﹤0.01% 317
2020
Q1 		$469 Buy
22,115
+3,884
+21% +$86.6K 0.01% 255
2019
Q4 		$407 Buy
18,231
+2,093
+13% +$45.7K 0.01% 327
2019
Q3 		$327 Buy
+16,138
New +$318K 0.01% 331

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Freestone Capital Holdings's GMAB Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Genmab (GMAB) in Q1 2021, closing a stake of 146 shares — an estimated $5.94K sold.

Freestone Capital Holdings first reported a position in GMAB in Q3 2019 and held it in 6 quarters. The position peaked at $9.92K in Q3 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 146 Genmab shares in Q1 2021, an estimated $5.94K.
  • Freestone Capital Holdings first reported a position in Genmab in Q3 2019 and held it in 6 quarters.
  • Freestone Capital Holdings's Genmab position peaked at $9.92K in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.